A Randomized, Double-Blind, Parallel-Group, Exploratory Clinical Study to Evaluate the Safety, Pharmacodynamic Effects, and Pharmacokinetic Characteristics of Multiple Subcutaneous Injections of LP-98 in Treatment-Naive HIV-Infected Individuals
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Changes from baseline in respiration rate of Vital Signs.
Timeframe: Within 71 days after the first administration.
Changes from baseline in blood pressure of Vital Signs.
Timeframe: Within 71 days after the first administration.
Changes from baseline in Blood lactate of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in body temperature of Vital Signs.
Timeframe: Within 71 days after the first administration.
Changes from baseline in red blood cell count of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in white blood cell count of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in neutrophil count of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in lymphocyte count of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in platelet count of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in hemoglobin of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in PT of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in INR of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in APTT of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in total bilirubin of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in direct bilirubin of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in ALT of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in AST of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in total protein of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in albumin of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urea of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in creatinine of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in uric acid of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in glucose of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in potassium of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in sodium of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in chlorine of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urine specific gravity of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urine pH of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urine glucose of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urine protein of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urine ketone body of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urine white blood cell of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urine bilirubin of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in urine occult blood of Laboratory Examination.
Timeframe: Within 71 days after the first administration.
Changes from baseline in Electrocardiogram.
Timeframe: Within 71 days after the first administration.
Changes from baseline in CK of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in CK-MB of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in LDH of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in ALP of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in Triglyceride of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in CHOL of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in TP of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in ALB of Laboratory Examination
Timeframe: Within 71 days after the first administration.
Changes from baseline in UA of Laboratory Examination
Timeframe: Within 71 days after the first administration.